BioNexus Gene Stock Forecast - Accumulation Distribution
| BGLC Stock | USD 0.29 0.01 3.33% |
BioNexus Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast BioNexus Gene stock prices and determine the direction of BioNexus Gene Lab's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of BioNexus Gene's historical fundamentals, such as revenue growth or operating cash flow patterns.
BioNexus |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 6619.78 | 6590.78 |
| Check BioNexus Gene Volatility | Backtest BioNexus Gene | Trend Details |
BioNexus Gene Trading Date Momentum
| On September 04 2024 BioNexus Gene Lab was traded for 0.43 at the closing time. The top price for the day was 0.44 and the lowest listed price was 0.42 . The trading volume for the day was 9.9 K. The trading history from September 4, 2024 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 2.38% . The overall trading delta against the current closing price is 7.14% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare BioNexus Gene to competition |
Other Forecasting Options for BioNexus Gene
For every potential investor in BioNexus, whether a beginner or expert, BioNexus Gene's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. BioNexus Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in BioNexus. Basic forecasting techniques help filter out the noise by identifying BioNexus Gene's price trends.View BioNexus Gene Related Equities
| Risk & Return | Correlation |
BioNexus Gene Lab Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of BioNexus Gene's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of BioNexus Gene's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
BioNexus Gene Market Strength Events
Market strength indicators help investors to evaluate how BioNexus Gene stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioNexus Gene shares will generate the highest return on investment. By undertsting and applying BioNexus Gene stock market strength indicators, traders can identify BioNexus Gene Lab entry and exit signals to maximize returns.
BioNexus Gene Risk Indicators
The analysis of BioNexus Gene's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in BioNexus Gene's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bionexus stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.72 | |||
| Standard Deviation | 3.5 | |||
| Variance | 12.22 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether BioNexus Gene Lab offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BioNexus Gene's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bionexus Gene Lab Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bionexus Gene Lab Stock:Check out Historical Fundamental Analysis of BioNexus Gene to cross-verify your projections. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Specialty Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioNexus Gene. If investors know BioNexus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioNexus Gene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.95) | Earnings Share (0.06) | Revenue Per Share 0.526 | Quarterly Revenue Growth (0.23) | Return On Assets (0.10) |
The market value of BioNexus Gene Lab is measured differently than its book value, which is the value of BioNexus that is recorded on the company's balance sheet. Investors also form their own opinion of BioNexus Gene's value that differs from its market value or its book value, called intrinsic value, which is BioNexus Gene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioNexus Gene's market value can be influenced by many factors that don't directly affect BioNexus Gene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioNexus Gene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioNexus Gene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioNexus Gene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.